What was PT UBC Medical Indonesia Tbk’s price range in the past 12 months?
PT UBC Medical Indonesia Tbk lowest stock price was IDR 119.00 and its highest was IDR 260.00 in the past 12 months.
What is PT UBC Medical Indonesia Tbk’s market cap?
PT UBC Medical Indonesia Tbk’s market cap is IDR 481.90B.
When is PT UBC Medical Indonesia Tbk’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were PT UBC Medical Indonesia Tbk’s earnings last quarter?
PT UBC Medical Indonesia Tbk released its earnings results on Oct 26, 2026. The company reported IDR 0.753 earnings per share for the quarter.
Is PT UBC Medical Indonesia Tbk overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does PT UBC Medical Indonesia Tbk pay dividends?
PT UBC Medical Indonesia Tbk does not currently pay dividends.
What is PT UBC Medical Indonesia Tbk’s EPS estimate?
PT UBC Medical Indonesia Tbk’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does PT UBC Medical Indonesia Tbk have?
PT UBC Medical Indonesia Tbk has 3,950,000,000 shares outstanding.
What happened to PT UBC Medical Indonesia Tbk’s price movement after its last earnings report?
PT UBC Medical Indonesia Tbk reported an EPS of IDR 0.753 in its last earnings report. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of PT UBC Medical Indonesia Tbk?
Currently, no hedge funds are holding shares in ID:LABS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
PT UBC Medical Indonesia Tbk
UBC Medical Indonesia Tbk (LABS.JK) serves as a key supplier of medical devices throughout Indonesia. The company's operations are structured into two primary divisions: Medical Disposables and Consumables, and Diagnostics and Equipment. Its comprehensive product lineup includes advanced solutions for next-generation molecular analysis, AI-driven retina diagnostics, infectious disease detection, HPV DNA testing, real-time PCR technology, TB management systems, and newborn screening. Established in 2014, UBC Medical Indonesia Tbk is headquartered in Jakarta Timur, Jakarta, and operates as a subsidiary under the ownership of PT Optel Investama Mulia.
Sector
General
Industry
Medical - Distribution
CEO
Franciscus Xaverius Yoshua Raintjung
Employees
54
Website
www.ubcindonesia.com
Address
Kawasan Industri Pulogadung, Jakarta Timur, JK, 13930, ID
PT UBC Medical Indonesia Tbk (LABS) Earnings & Revenues